Experimentally Testing the Effectiveness of a Campus-based Bystander Intervention

March 7, 2014 updated by: Rutgers, The State University of New Jersey
The purpose of this study was to examine the impact of a bystander intervention education program on college students' attitudes and behaviors associated with bystander intervention and sexual violence.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study used a randomized control trial, longitudinal design to determine the impact of a peer education theater intervention on undergraduate student attitudes and behaviors related to sexual violence and bystander intervention. Students were assigned to either an experimental group (receiving 3-4 doses of the intervention ) or a comparison group (receiving 1 dose only) and were surveyed six times over an 18 month period.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
4385

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New Jersey
      • New Brunswick, New Jersey, United States, 08901
        • Rutgers, The State University of New Jersey

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 21 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Incoming first year students in the fall semester of 2010
  • Age 18 - 21
  • Attended Summer Orientation session

Exclusion Criteria:

  • Incoming transfer students
  • Younger than 18 or older than 21

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Treatment1
The Treatment1 group received SCREAM Theater Dose 1, SCREAM Theater Dose 2 and SCREAM Theater Dose 3.
Behavioral: SCREAM Theater Dose 1
Intervention 1: A three part program: a skit acted out by peer educators that depicts a sexual assault; an in-character question and answer session; and an out-of-character information session.
Behavioral: SCREAM Theater Doses 2 & SCREAM Theater Dose 3

Dose 2: Scenes from the skit from Session 1 are re-created with small groups of students, but stop at certain points to allow audience members to explore different bystander intervention possibilities.

Dose 3: The six scenes outlined in Session 2 are presented individually to small groups of student participants; specifically outlining potential points of bystander intervention.
Experimental: Treatment2
The Treatment2 group received SCREAM Theater Dose 1, SCREAM Theater Dose 2, SCREAM Theater Dose 3 and SCREAM Theater Dose 4.
Behavioral: SCREAM Theater Dose 1
Intervention 1: A three part program: a skit acted out by peer educators that depicts a sexual assault; an in-character question and answer session; and an out-of-character information session.
Behavioral: SCREAM Theater Doses 2 & SCREAM Theater Dose 3

Dose 2: Scenes from the skit from Session 1 are re-created with small groups of students, but stop at certain points to allow audience members to explore different bystander intervention possibilities.

Dose 3: The six scenes outlined in Session 2 are presented individually to small groups of student participants; specifically outlining potential points of bystander intervention.

Behavioral: SCREAM Theater Dose 4
Booster Session
Other: Control
The control group received SCREAM Theater Dose 1.
Behavioral: SCREAM Theater Dose 1
Intervention 1: A three part program: a skit acted out by peer educators that depicts a sexual assault; an in-character question and answer session; and an out-of-character information session.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Bystander Intentions
Time Frame: Change from baseline in bystander intentions to up to three months
To measure intentions to be a bystander, we used the Bystander Attitude Scale, Revised (BAS-R) which is a modified version of Banyard's Bystander scale (Banyard, Plante, & Moynihan, 2005; see McMahon et al., in press, for scale development information). Participants were asked to indicate how likely they were to engage in the behavior in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely." Students' bystander intentions were assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010. All study participants received one dose of the intervention in June, July or August.
Change from baseline in bystander intentions to up to three months
Bystander Intentions
Time Frame: Change from baseline in bystander intentions to up to six months
To measure intentions to be a bystander, we used the Bystander Attitude Scale, Revised (BAS-R) which is a modified version of Banyard's Bystander scale (Banyard, Plante, & Moynihan, 2005; see McMahon et al., in press, for scale development information). Participants were asked to indicate how likely they were to engage in the behavior in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely." Students' bystander intentions were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010. After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
Change from baseline in bystander intentions to up to six months
Bystander Intentions
Time Frame: Change from baseline in bystander intentions to up to eight months
To measure intentions to be a bystander, we used the Bystander Attitude Scale, Revised (BAS-R) which is a modified version of Banyard's Bystander scale (Banyard, Plante, & Moynihan, 2005; see McMahon et al., in press, for scale development information). Participants were asked to indicate how likely they were to engage in the behavior in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely." Students' bystander intentions were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; and (4) a follow-up web-based survey in February, 2011.
Change from baseline in bystander intentions to up to eight months
Bystander Intentions
Time Frame: Change from baseline in bystander intentions to up to fifteen months
To measure intentions to be a bystander, we used the Bystander Attitude Scale, Revised (BAS-R) which is a modified version of Banyard's Bystander scale (Banyard, Plante, & Moynihan, 2005; see McMahon et al., in press, for scale development information). Participants were asked to indicate how likely they were to engage in the behavior in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely." Students' bystander intentions were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011. After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
Change from baseline in bystander intentions to up to fifteen months
Bystander Intentions
Time Frame: Change from baseline in bystander intentions to up to twenty months
To measure intentions to be a bystander, we used the Bystander Attitude Scale, Revised (BAS-R) which is a modified version of Banyard's Bystander scale (Banyard, Plante, & Moynihan, 2005; see McMahon et al., in press, for scale development information). Participants were asked to indicate how likely they were to engage in the behavior in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely." Students' bystander intentions were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
Change from baseline in bystander intentions to up to twenty months

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Bystander Friend Norms
Time Frame: Change from baseline in bystander friend norms to up to three months
To measure friends' norms about being a bystander, we used the Bystander Attitude Scale, Revised (BAS-R). In this portion of the survey, participants were asked to indicate how likely they think their friends would be to engage in the items on the BAS-R in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely."Students' bystander friend norms were assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010. All study participants received one dose of the intervention in June, July or August.
Change from baseline in bystander friend norms to up to three months
Bystander Friend Norms
Time Frame: Change from baseline in bystander friend norms to up to six months
To measure friends' norms about being a bystander, we used the Bystander Attitude Scale, Revised (BAS-R). In this portion of the survey, participants were asked to indicate how likely they think their friends would be to engage in the items on the BAS-R in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely." Students' bystander friend norms were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010. After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
Change from baseline in bystander friend norms to up to six months
Bystander Friend Norms
Time Frame: Change from baseline in bystander friend norms to up to eight months
To measure friends' norms about being a bystander, we used the Bystander Attitude Scale, Revised (BAS-R). In this portion of the survey, participants were asked to indicate how likely they think their friends would be to engage in the items on the BAS-R in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely." Students' bystander friend norms were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; and (4) a follow-up web-based survey in February, 2011.
Change from baseline in bystander friend norms to up to eight months
Bystander Friend Norms
Time Frame: Change from baseline in bystander friend norms to up to fifteen months
To measure friends' norms about being a bystander, we used the Bystander Attitude Scale, Revised (BAS-R). In this portion of the survey, participants were asked to indicate how likely they think their friends would be to engage in the items on the BAS-R in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely." Students' bystander friend norms were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011. After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
Change from baseline in bystander friend norms to up to fifteen months
Bystander Friend Norms
Time Frame: Change from baseline in bystander friend norms to up to twenty months
To measure friends' norms about being a bystander, we used the Bystander Attitude Scale, Revised (BAS-R). In this portion of the survey, participants were asked to indicate how likely they think their friends would be to engage in the items on the BAS-R in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely." Students' bystander friend norms were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
Change from baseline in bystander friend norms to up to twenty months
Bystander Efficacy
Time Frame: Change from baseline in bystander efficacy to up to three months
To assess level of confidence in one's ability to intervene, the Bystander Efficacy Scale was used (Banyard et al., 2007). Respondents were asked to rate their level of confidence that they would perform certain bystander behaviors on a scale of 0 ("can't do") to 100 ("very certain can do"). Students' bystander efficacy was assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010. All study participants received one dose of the intervention in June, July or August.
Change from baseline in bystander efficacy to up to three months
Bystander Efficacy
Time Frame: Change from baseline in bystander efficacy to up to six months
To assess level of confidence in one's ability to intervene, the Bystander Efficacy Scale was used (Banyard et al., 2007). Respondents were asked to rate their level of confidence that they would perform certain bystander behaviors on a scale of 0 ("can't do") to 100 ("very certain can do").Students' bystander efficacy was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010. After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
Change from baseline in bystander efficacy to up to six months
Bystander Efficacy
Time Frame: Change from baseline in bystander efficacy to up to eight months
To assess level of confidence in one's ability to intervene, the Bystander Efficacy Scale was used (Banyard et al., 2007). Respondents were asked to rate their level of confidence that they would perform certain bystander behaviors on a scale of 0 ("can't do") to 100 ("very certain can do"). Students' bystander efficacy was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; and (4) a follow-up web-based survey in February, 2011.
Change from baseline in bystander efficacy to up to eight months
Bystander Efficacy
Time Frame: Change from baseline in bystander efficacy to up to fifteen months
To assess level of confidence in one's ability to intervene, the Bystander Efficacy Scale was used (Banyard et al., 2007). Respondents were asked to rate their level of confidence that they would perform certain bystander behaviors on a scale of 0 ("can't do") to 100 ("very certain can do"). Students' bystander efficacy was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011. After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
Change from baseline in bystander efficacy to up to fifteen months
Bystander Efficacy
Time Frame: Change from baseline in bystander efficacy to up to twenty months
To assess level of confidence in one's ability to intervene, the Bystander Efficacy Scale was used (Banyard et al., 2007). Respondents were asked to rate their level of confidence that they would perform certain bystander behaviors on a scale of 0 ("can't do") to 100 ("very certain can do"). Students' bystander intentions were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
Change from baseline in bystander efficacy to up to twenty months
Bystander Behavior
Time Frame: Change from baseline in bystander behavior to up to three months
To measure actual bystander behavior, we used the Bystander Attitude Scale, Revised (BAS-R), which contains 18 items, each stating a different bystander behavior. For this portion of the survey, participants were asked whether they actually participated in the behavior in the previous month. Respondents can indicate "Yes", "No", or "Wasn't in the Situation".Students' bystander behavior was assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010. All study participants received one dose of the intervention in June, July or August.
Change from baseline in bystander behavior to up to three months
Bystander Behavior
Time Frame: Change from baseline in bystander behavior to up to six months
To measure actual bystander behavior, we used the Bystander Attitude Scale, Revised (BAS-R), which contains 18 items, each stating a different bystander behavior. For this portion of the survey, participants were asked whether they actually participated in the behavior in the previous month. Respondents can indicate "Yes", "No", or "Wasn't in the Situation".Students' bystander behavior was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010. After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
Change from baseline in bystander behavior to up to six months
Bystander Behavior
Time Frame: Change from baseline in bystander behavior to up to eight months
To measure actual bystander behavior, we used the Bystander Attitude Scale, Revised (BAS-R), which contains 18 items, each stating a different bystander behavior. For this portion of the survey, participants were asked whether they actually participated in the behavior in the previous month. Respondents can indicate "Yes", "No", or "Wasn't in the Situation". Students' bystander behavior was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; and (4) a follow-up web-based survey in February, 2011.
Change from baseline in bystander behavior to up to eight months
Bystander Behavior
Time Frame: Change from baseline in bystander behavior to up to fifteen months
To measure actual bystander behavior, we used the Bystander Attitude Scale, Revised (BAS-R), which contains 18 items, each stating a different bystander behavior. For this portion of the survey, participants were asked whether they actually participated in the behavior in the previous month. Respondents can indicate "Yes", "No", or "Wasn't in the Situation".Students' bystander behavior was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011. After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
Change from baseline in bystander behavior to up to fifteen months
Bystander Behavior
Time Frame: Change from baseline in bystander behavior to up to twenty months
To measure actual bystander behavior, we used the Bystander Attitude Scale, Revised (BAS-R), which contains 18 items, each stating a different bystander behavior. For this portion of the survey, participants were asked whether they actually participated in the behavior in the previous month. Respondents can indicate "Yes", "No", or "Wasn't in the Situation". Students' bystander behavior was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
Change from baseline in bystander behavior to up to twenty months
Rape Myth Acceptance
Time Frame: Change from baseline in rape myth acceptance to up to three months
A revised version of the Illinois Rape Myth Acceptance Scale (Payne, Lonsway, & Fitzgerald, 1999) was used. The revised version (McMahon & Farmer, 2011) was selected because the scale includes updated language for college students as well as having a specific focus on accountability for rape and victim blaming (for information on scale development, see McMahon & Farmer, 2011). Students' rape myth acceptance was assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010. All study participants received one dose of the intervention in June, July or August.
Change from baseline in rape myth acceptance to up to three months
Rape Myth Acceptance
Time Frame: Change from baseline in rape myth acceptance to up to six months
A revised version of the Illinois Rape Myth Acceptance Scale (Payne, Lonsway, & Fitzgerald, 1999) was used. The revised version (McMahon & Farmer, 2011) was selected because the scale includes updated language for college students as well as having a specific focus on accountability for rape and victim blaming (for information on scale development, see McMahon & Farmer, 2011).Students' rape myth acceptance was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010. After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
Change from baseline in rape myth acceptance to up to six months
Rape Myth Acceptance
Time Frame: Change from baseline in rape myth acceptance to up to eight months
A revised version of the Illinois Rape Myth Acceptance Scale (Payne, Lonsway, & Fitzgerald, 1999) was used. The revised version (McMahon & Farmer, 2011) was selected because the scale includes updated language for college students as well as having a specific focus on accountability for rape and victim blaming (for information on scale development, see McMahon & Farmer, 2011). Students' rape myth acceptance was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011.
Change from baseline in rape myth acceptance to up to eight months
Rape Myth Acceptance
Time Frame: Change from baseline in rape myth acceptance to up to fifteen months
A revised version of the Illinois Rape Myth Acceptance Scale (Payne, Lonsway, & Fitzgerald, 1999) was used. The revised version (McMahon & Farmer, 2011) was selected because the scale includes updated language for college students as well as having a specific focus on accountability for rape and victim blaming (for information on scale development, see McMahon & Farmer, 2011).Students' rape myth acceptance was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011. After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
Change from baseline in rape myth acceptance to up to fifteen months
Rape Myth Acceptance
Time Frame: Change from baseline in rape myth acceptance to up to twenty months
A revised version of the Illinois Rape Myth Acceptance Scale (Payne, Lonsway, & Fitzgerald, 1999) was used. The revised version (McMahon & Farmer, 2011) was selected because the scale includes updated language for college students as well as having a specific focus on accountability for rape and victim blaming (for information on scale development, see McMahon & Farmer, 2011).Students' rape myth acceptance assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
Change from baseline in rape myth acceptance to up to twenty months
Proclivity to Perpetrate Sexual Violence
Time Frame: Change from baseline in proclivity to perpetrate sexual violence to up to three months
For proclivity to perpetrate, we used an item from Malamuth's (1989) Attraction to Sexual Aggression Scale and we created a question that combined items from Malamuth's scale and Lisak's Perpetrator History (PH) Scale (2000). These measures were assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010. All study participants received one dose of the intervention in June, July or August.
Change from baseline in proclivity to perpetrate sexual violence to up to three months
Proclivity to Perpetrate Sexual Violence
Time Frame: Change from baseline in proclivity to perpetrate sexual violence to up to six months
For proclivity to perpetrate, we used an item from Malamuth's (1989) Attraction to Sexual Aggression Scale and we created a question that combined items from Malamuth's scale and Lisak's Perpetrator History (PH) Scale (2000). These measures were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010. After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
Change from baseline in proclivity to perpetrate sexual violence to up to six months
Proclivity to Perpetrate Sexual Violence
Time Frame: Change from baseline in proclivity to perpetrate sexual violence to up to eight months
For proclivity to perpetrate, we used an item from Malamuth's (1989) Attraction to Sexual Aggression Scale and we created a question that combined items from Malamuth's scale and Lisak's Perpetrator History (PH) Scale (2000). These measures were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; and (4) a follow-up web-based survey in February, 2011.
Change from baseline in proclivity to perpetrate sexual violence to up to eight months
Proclivity to Perpetrate Sexual Violence
Time Frame: Change from baseline in proclivity to perpetrate sexual violence up to fifteen months
For proclivity to perpetrate, we used an item from Malamuth's (1989) Attraction to Sexual Aggression Scale and we created a question that combined items from Malamuth's scale and Lisak's Perpetrator History (PH) Scale (2000). These measures were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011. After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
Change from baseline in proclivity to perpetrate sexual violence up to fifteen months
Proclivity to Perpetrate Sexual Violence
Time Frame: Change from baseline in proclivity to perpetrate sexual violence to up to twenty months
For proclivity to perpetrate, we used an item from Malamuth's (1989) Attraction to Sexual Aggression Scale and we created a question that combined items from Malamuth's scale and Lisak's Perpetrator History (PH) Scale (2000). These measures were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
Change from baseline in proclivity to perpetrate sexual violence to up to twenty months
Sexual Violence Perpetration
Time Frame: Change from baseline in sexual violence perpetration to up to three months
Two questions from Lisak's Perpetrator History (PH) Scale (Lisak, Conklin, Hopper, Miller, Altschuler & Smith, 2000) were used to assess actual perpetration. Students' past perpetration was assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010. All study participants received one dose of the intervention in June, July or August.
Change from baseline in sexual violence perpetration to up to three months
Sexual Violence Perpetration
Time Frame: Change from baseline in sexual violence perpetration to up to six months
Two questions from Lisak's Perpetrator History (PH) Scale (Lisak, Conklin, Hopper, Miller, Altschuler & Smith, 2000) were used to assess actual perpetration. Students' past perpetration was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010. After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
Change from baseline in sexual violence perpetration to up to six months
Sexual Violence Perpetration
Time Frame: Change from baseline in sexual violence perpetration to up to eight months
Two questions from Lisak's Perpetrator History (PH) Scale (Lisak, Conklin, Hopper, Miller, Altschuler & Smith, 2000) were used to assess actual perpetration. Students' past perpetration was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; and (4) a follow-up web-based survey in February, 2011.
Change from baseline in sexual violence perpetration to up to eight months
Sexual Violence Perpetration
Time Frame: Change from baseline in sexual violence perpetration to up to fifteen months
Two questions from Lisak's Perpetrator History (PH) Scale (Lisak, Conklin, Hopper, Miller, Altschuler & Smith, 2000) were used to assess actual perpetration. Students' past perpetration was assessed via(1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011. After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
Change from baseline in sexual violence perpetration to up to fifteen months
Sexual Violence Perpetration
Time Frame: Change from baseline in sexual violence perpetration to up to twenty months
Two questions from Lisak's Perpetrator History (PH) Scale (Lisak, Conklin, Hopper, Miller, Altschuler & Smith, 2000) were used to assess actual perpetration. Students' past perpetration was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
Change from baseline in sexual violence perpetration to up to twenty months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Rutgers, The State University of New Jersey

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Centers for Disease Control and Prevention

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Sarah McMahon, PhD, Rutgers University School of Social Work
  • Principal Investigator: Judy Postmus, PhD, Rutgers University School of Social Work

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
June 1, 2010

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 1, 2012

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 1, 2012

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 3, 2014

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 7, 2014

First Posted (Estimate)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 11, 2014

Study Record Updates

Last Update Posted (Estimate)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 11, 2014

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 7, 2014

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2014

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 07-412M
  • 1R01CE001855-01 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings